Serina Therapeutics
Price & Volume
Stats
See more52W Range | $3.81-$8.14 |
Market Cap | $51.5M |
Shares Short | 82,003 |
Financials
See moreRevenue (12 Mos) | $130,000 |
Revenue Growth (YoY) | 154.9% |
Gross Profit (12 Mos) | -$10.7M |
Diluted EPS | -$0.91 |
News
See moreYahoo Finance • 22 days ago
Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson’s Disease
Yahoo Finance • 24 days ago
Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Yahoo Finance • last month
Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson’s Disease under 505(b)(2) NDA Pathway
Yahoo Finance • 2 months ago
Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights
About
CEO | Mr. Steven A. Ledger |
Address | 601 Genome Way, Huntsville, AL, United States, 35806 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 12 |
